• FDA clears Turnstone Biologics' IND for immunotherapy targeting HPV positive solid tumors

    3 monthes ago - By News Medical

    Turnstone Biologics today announced it has received U.S. Food and Drug Administration clearance of its Investigational New Drug Application for MG1-HPV for the treatment of patients with human papillomavirus positive solid tumors.
    Read more ...